Financial results - HEMATOLOGY RESEARCH S.R.L.

Financial Summary - Hematology Research S.r.l.
Unique identification code: 40849316
Registration number: J2019001054163
Nace: 8621
Sales - Ron
4.424
Net Profit - Ron
3.395
Employees
Open Account
Company Hematology Research S.r.l. with Fiscal Code 40849316 recorded a turnover of 2024 of 4.424, with a net profit of 3.395 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Hematology Research S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 184 2.779 5.255 2.979 1.308 4.424
Total Income - EUR - - - - 184 2.779 5.255 2.990 1.348 4.424
Total Expenses - EUR - - - - 103 435 2.089 677 161 362
Gross Profit/Loss - EUR - - - - 81 2.344 3.166 2.313 1.188 4.061
Net Profit/Loss - EUR - - - - 75 2.261 3.008 2.224 978 3.395
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 240.2%, from 1.308 euro in the year 2023, to 4.424 euro in 2024. The Net Profit increased by 2.423 euro, from 978 euro in 2023, to 3.395 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Hematology Research S.r.l.

Rating financiar

Financial Rating -
HEMATOLOGY RESEARCH S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Hematology Research S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hematology Research S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Hematology Research S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hematology Research S.r.l. - CUI 40849316

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 621 623 615 551
Current Assets - - - - 119 2.420 4.874 7.016 7.930 11.536
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 0 0 0 866 0 929
Cash - - - - 119 2.420 4.874 6.150 7.930 10.608
Shareholders Funds - - - - 117 2.376 5.331 7.571 8.526 11.874
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 2 44 164 68 19 213
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 11.536 euro in 2024 which includes Inventories of 0 euro, Receivables of 929 euro and cash availability of 10.608 euro.
The company's Equity was valued at 11.874 euro, while total Liabilities amounted to 213 euro. Equity increased by 3.395 euro, from 8.526 euro in 2023, to 11.874 in 2024.

Risk Reports Prices

Reviews - Hematology Research S.r.l.

Comments - Hematology Research S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.